| 000 | 01391 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517101547.0 | ||
| 264 | 0 | _c20170208 | |
| 008 | 201702s 0 0 eng d | ||
| 022 | _a1873-376X | ||
| 024 | 7 |
_a10.1016/j.jchromb.2016.05.045 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSuárez, Inmaculada | |
| 245 | 0 | 0 |
_aDevelopment and use of specific ELISA methods for quantifying the biological activity of bevacizumab, cetuximab and trastuzumab in stability studies. _h[electronic resource] |
| 260 |
_bJournal of chromatography. B, Analytical technologies in the biomedical and life sciences _cOct 2016 |
||
| 300 |
_a155-164 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemistry |
| 650 | 0 | 4 |
_aBevacizumab _xchemistry |
| 650 | 0 | 4 |
_aCetuximab _xchemistry |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 |
_aEnzyme-Linked Immunosorbent Assay _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aProtein Stability |
| 650 | 0 | 4 |
_aTrastuzumab _xchemistry |
| 700 | 1 | _aSalmerón-García, Antonio | |
| 700 | 1 | _aCabeza, José | |
| 700 | 1 | _aCapitán-Vallvey, Luis Fermín | |
| 700 | 1 | _aNavas, Natalia | |
| 773 | 0 |
_tJournal of chromatography. B, Analytical technologies in the biomedical and life sciences _gvol. 1032 _gp. 155-164 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jchromb.2016.05.045 _zAvailable from publisher's website |
| 999 |
_c26120125 _d26120125 |
||